$4.13
0.00%
Nasdaq, Oct 13, 04:00 pm EDT.
ISIN
US7507231089
Symbol
RADLY

Raia Drogasil Adr Target price 2026 - Analyst rating & recommendation

Raia Drogasil Adr Classifications & Recommendation

Buy
80%
Hold
15%
Sell
5%

Raia Drogasil Adr Price Target

Target Price $5.45
Price $4.01
Potential
Number of Estimates 15
15 Analysts have issued a price target Raia Drogasil Adr 2027 . The average Raia Drogasil Adr target price is $5.45. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 20 analysts: 16 Analysts recommend Raia Drogasil Adr to buy, 3 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Raia Drogasil Adr stock has an average upside potential 2027 of . Most analysts recommend the Raia Drogasil Adr stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

15 Analysts have issued a sales forecast Raia Drogasil Adr 2026 . The average Raia Drogasil Adr sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 $8.8b 13.84%
2026
2027
2028
2029

15 Analysts have issued an Raia Drogasil Adr EBITDA forecast 2026. The average Raia Drogasil Adr EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $928m 11.77%
2026
2027
2028
2029

EBITDA Margin

2025 10.59% 1.81%
2026
2027
2028
2029

14 Raia Drogasil Adr Analysts have issued a net profit forecast 2026. The average Raia Drogasil Adr net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $257m 8.08%
2026
2027
2028
2029

Net Margin

2025 2.93% 5.05%
2026
2027
2028
2029

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

14 Analysts have issued a Raia Drogasil Adr forecast for earnings per share. The average Raia Drogasil Adr EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $0.15 7.14%
2026
2027
2028
2029

P/E ratio

Current 25.06 18.67%
2026
2027
2028
2029

Based on analysts' sales estimates for 2026, the Raia Drogasil Adr stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.98
2026
2027
2028
2029

P/S ratio

Current
2026
2027
2028
2029

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today